Current Abbvie Foundation Professor in Cancer Immunotherapy, Leader of the Immunology and Cancer program, Director of Melanoma Oncology, University of Chicago
Formerly President of the Society for Immunotherapy of Cancer
Published more than 200 papers in T cell biology, anti-tumor immunity, and melanoma therapy, including discovery of a role for the STING pathway, immune-evasive oncogenic events, and the microbiome
Editor for Journal of Experimental Medicine and Journal for Immunotherapy of Cancer
Recipient of numerous awards including the Burroughs Wellcome Fund Clinical Scientist Award for Translational Research, the American Cancer Society-Jules L. Plangere Jr. Family Foundation Professorship in Cancer Immunotherapy, and the Coley Award.
B.A., Ph.D., M.D., University of Chicago; Postdoctoral Fellow at Ludwig Institute for Cancer Research in Belgium and University of Chicago